Abbott Labs gets FDA emergency authorization for another Covid-19 test

Abbott Laboratories said it's received an emergency use authorization from the U.S. Food and Drug Administration for another test for Covid-19. The latest Abbott Labs (NYSE: ABT) test is its new "Alinity m" molecular laboratory instrument, which was cleared by the FDA for use with its hepatitis C test in late March. The company said "Alinity m" improves speed and efficiency and can run up to 1,080 Covid-19 tests in 24 hours. "Molecular l ab tests play a critical role in detecting the virus for Covid-19.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news